VYNE Therapeutics Inc. (VYNE)
NASDAQ: VYNE · IEX Real-Time Price · USD
2.960
+0.130 (4.59%)
At close: Mar 27, 2024, 4:00 PM
2.850
-0.110 (-3.72%)
After-hours: Mar 27, 2024, 7:30 PM EDT

VYNE Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021202020192018201720162015
Cash & Equivalents
30.6730.9842.8658.4244.5849.5110.214.0343.81
Short-Term Investments
62.63001.0328.7886.7449.326.880
Cash & Cash Equivalents
93.3130.9842.8659.4573.37136.2559.530.9143.81
Cash Growth
201.23%-27.72%-27.91%-18.97%-46.15%128.99%92.51%-29.45%-
Receivables
007.5815.820.1400.7900
Inventory
0007.41.360000
Other Current Assets
2.667.312.754.591.563.253.570.630.08
Total Current Assets
95.9638.2863.1987.2676.41139.563.8631.5443.89
Property, Plant & Equipment
0.2100.692.144.580.150.030.030
Long-Term Investments
0000002.9810.420
Other Long-Term Assets
1.522.483.174.350.170.2800.070
Total Long-Term Assets
1.722.483.866.484.750.433.0110.510
Total Assets
97.6940.7667.0593.7481.16139.9366.8742.0543.89
Accounts Payable
1.662.396.514.7819.353.292.461.530.64
Deferred Revenue
0000008.5310.330
Current Debt
0.1200.350.761.090000
Other Current Liabilities
5.766.9611.5516.238.886.25-3.18-7.950.13
Total Current Liabilities
7.549.3518.4121.7729.339.547.823.90.77
Long-Term Debt
0.10034.0333.380000
Other Long-Term Liabilities
1.31000.460.880.016.768.590.07
Total Long-Term Liabilities
1.410034.4834.260.016.768.590.07
Total Liabilities
8.959.3518.4156.2563.589.5514.5712.490.84
Total Debt
0.2100.3534.7834.470000
Debt Growth
---99.00%0.91%-----
Retained Earnings
-691.34-662.74-639.53-566.2-310.59-110.64-59.19-30.12-16.05
Comprehensive Income
0.030000.01-0.1-0.05-0.030
Shareholders' Equity
88.7431.248.6437.4917.58130.38-57.03-29.44-15.95
Net Cash / Debt
93.0930.9842.5124.6638.9136.2559.530.9143.81
Net Cash / Debt Growth
200.54%-27.13%72.36%-36.60%-71.45%128.99%92.51%-29.45%-
Net Cash Per Share
9.069.7214.8713.6982.51379.29838.68446.22666.12
Working Capital
88.4328.9344.7865.4947.09129.9656.0427.6443.12
Book Value Per Share
8.649.7917.0120.8237.28362.94-803.91-425.04-242.57
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).